{
    "nctId": "NCT00608452",
    "briefTitle": "Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers",
    "officialTitle": "A Prospective Study of The Prevalence and Significance of Paraneoplastic Autoantibodies in Small Cell Lung Cancer and Cancer of The Breast, Ovary, Hodgkin's Disease, Neuroblastoma and Other Cancers",
    "overallStatus": "COMPLETED",
    "conditions": "Lung Cancer, Ovarian Cancer, Breast Cancer, Hodgkin's Disease, Neuroblastoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 121,
    "primaryOutcomeMeasure": "Blood samples for autoantibody determinations and HLA typing and clinical evaluations via Symptom Assessment Scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with previous cancers or concurrent cancers. Patient has or may have, newly-diagnosed or recurrent SCLC, or mixed small cell/non small cell lung cancer, or neuroblastoma, or ovarian or breast cancer, or Hodgkin's disease in all cases confirmed by pathological review.\n\nExclusion Criteria:\n\n* Patient refusal to participate in follow-up clinical evaluations. For minors, parental or guardian refusal.\n* Patient refusal to provide blood samples for autoantibody determinations and HLA typing (total 4 tubes).",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}